Skip to main content
OpenTrials
Completed

NCT Number: NCT06556017

Assessment of the Efficacy of ChatGPT in Detecting Surgical Site Infections Following Elective Colorectal Surgery

Epidemiological surveillance is one of the eight core components of the World Health Organization Infection Prevention and Control Programmes. These include surveillance programmes for surgical site infection (SSI).

At present, for SSI surveillance, infection control teams perform a manual time-consuming work, which could make a transition to automated surveillance leveraging the new information technology.

This study aimed to evaluate the ability of ChatGPT-4o to detect surgical site infection at the three anatomical levels.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital General de Granollers

Granollers, Barcelona, 08402, Spain

About this study

Healthcare-associated infections (HAIs) have a negative impact on patient health, represent a significant healthcare and economic burden on healthcare systems and are considered the most preventable cause of serious adverse events in hospitalised patients.

Epidemiological surveillance is one of the eight core components of the World Health Organization (WHO) Infection Prevention and Control Programmes. These include surveillance programmes for surgical site infection (SSI), which have proven to be effective in all types of surgery and in a variety of settings.

For a programme to be effective, surveillance for HCAIs must be active, prospective and continuous, comprising a surveillance period up to 30-90 days post-intervention, to cover the high rate of SSIs detected after discharge.

At present, infection control teams perform a manual, prospective, time-consuming and almost artisanal work, which should make a transition to automated or semi-automated surveillance that leverages the possibilities offered by today's information technology.

The evolution of surveillance systems should benefit from this new possibilities offered by artificial intelligence, allowing automated detection of suspected SSI adverse events from clinical course text, microbiology reports or coding of diagnoses, procedures, complications and readmissions.

This pilot study aims to evaluate the ability of ChatGPT to detect surgical site infections (SSI) at the three anatomical levels described by the CDC. The aim is to retrospectively compare the results of the AI chatbot in diagnosing SSI, trained using the US CDC definition criteria, with a cohort of elective colorectal surgery patients evaluated through a nationwide nosocomial infection surveillance system.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Elective colorectal resection

Exclusion criteria

  • Emergency surgery
  • Infection present at operation
  • Previous intestinal stoma

Treatment and study plan

Diagnosis of SSI

Diagnostic Test

Comparison of the manual system and ChatGPT for SSI diagnosis in colorectal surgery procedures enrolled in the SSI surveillance programme.

Primary outcomes

  1. Rate of surgical site infection

    Time frame: 30 days

    Rate of Surgical site infection according to the definitions of the CDC-NHSN (Centers for Disease Control and Prevention-National Healthcare Safety Network)

Sponsors and collaborators

Lead sponsor

Hospital de Granollers

Other

Registry information

Official study title

Assessing the Efficacy of ChatGPT in Detecting Surgical Site Infections Following Elective Colorectal Surgery

Acronym: ChatCCR

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Aug 15, 2024
Registry last updated
Oct 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.